{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:09:34Z","timestamp":1794262174144,"version":"4.9.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJ9-192251"],"award-info":[{"award-number":["PJ9-192251"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP190561"],"award-info":[{"award-number":["RP190561"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["AU-0042-20030616"],"award-info":[{"award-number":["AU-0042-20030616"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Endotrophin is a novel circulating fibroinflammatory protein that has recently been associated with cardiovascular disease (CVD) and all-cause mortality. However, little is known about its role early in the natural history of vascular disease nor whether it exhibits ethnicity-specific variation. Recognizing that South Asians have an elevated risk of ultimately developing CVD, we sought to address these questions by characterizing endotrophin and its physiologic correlates in young South Asian women as compared to White women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From a cohort recruited in pregnancy and followed to 1-year after delivery, we identified 40 participants of South Asian descent and 40 age- and BMI-matched White women. These individuals underwent cardiometabolic characterization at 1-year postpartum, including assessment of anthropometrics, blood pressure, glucose tolerance, insulin resistance, pancreatic beta-cell function, and serum endotrophin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There was no significant difference in serum endotrophin concentration between South Asians and Whites (median 19.3\u00a0ng\/ml [interquartile range 14.5\u201323.8] vs 17.3\u00a0ng\/ml [14.4\u201321.7],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.37). However, endotrophin was positively correlated with systolic blood pressure (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.43,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006) in South Asians but not in White women (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009-0.02,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.89), mirroring differential associations that were similarly observed with fasting glucose (South Asian:\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.34,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03; White:\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009-0.21,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.21). Moreover, on multiple linear regression analyses, systolic blood pressure was independently associated with endotrophin in South Asians only (beta\u2009=\u20090.016,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Endotrophin relates to blood pressure in young South Asian women but not White women, suggesting ethnic variation in its early vascular associations that potentially could be relevant to the elevated lifetime risk of CVD in South Asians.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-025-05153-1","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:32:44Z","timestamp":1759152764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum endotrophin relates to blood pressure in young South Asian women but not White women: evidence of ethnic variation in its early vascular implications"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1989-027X","authenticated-orcid":false,"given":"Ravi","family":"Retnakaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip W.","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Zinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp E.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"issue":"3","key":"5153_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1210\/endrev\/bnad036","volume":"45","author":"K Henriksen","year":"2024","unstructured":"Henriksen K, Genovese F, Reese-Petersen A, Audoly LP, Sun K, Karsdal MA, et al. Endotrophin, a key marker and driver for fibroinflammatory disease. Endocr Rev. 2024;45(3):361\u201378.","journal-title":"Endocr Rev"},{"issue":"11","key":"5153_CR2","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1172\/JCI63930","volume":"122","author":"J Park","year":"2012","unstructured":"Park J, Scherer PE. Adipocyte-derived endotrophin promotes malignant tumor progression. J Clin Invest. 2012;122(11):4243\u201356.","journal-title":"J Clin Invest"},{"key":"5153_CR3","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1038\/ncomms4485","volume":"5","author":"K Sun","year":"2014","unstructured":"Sun K, Park J, Gupta OT, Holland WL, Auerbach P, Zhang N, et al. Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction. Nat Commun. 2014;5:3485.","journal-title":"Nat Commun"},{"issue":"1","key":"5153_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/joim.13253","volume":"290","author":"S Holm Nielsen","year":"2021","unstructured":"Holm Nielsen S, Edsfeldt A, Tengryd C, Gustafsson H, Shore AC, Natali A, et al. The novel collagen matrikine, endotrophin, is associated with mortality and cardiovascular events in patients with atherosclerosis. J Intern Med. 2021;290(1):179\u201389.","journal-title":"J Intern Med"},{"key":"5153_CR5","doi-asserted-by":"publisher","unstructured":"Chirinos JA, Zhao L, Reese-Petersen AL, Cohen JB, Genovese F, Richards AM et al. Endotrophin, a collagen VI formation-derived peptide, in heart failure. NEJM Evid. 2022;1(10). https:\/\/doi.org\/10.1056\/evidoa2200091.","DOI":"10.1056\/evidoa2200091"},{"issue":"7","key":"5153_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110104","volume":"27","author":"PC Lee","year":"2024","unstructured":"Lee PC, Jung IH, Thussu S, Patel V, Wagoner R, Burks KH, et al. Instrumental variable and colocalization analyses identify endotrophin and HTRA1 as potential therapeutic targets for coronary artery disease. iScience. 2024;27(7):110104.","journal-title":"iScience"},{"issue":"11","key":"5153_CR7","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.2337\/dc22-0852","volume":"45","author":"NH Tougaard","year":"2022","unstructured":"Tougaard NH, M\u00f8ller AL, R\u00f8nn PF, Hansen TW, Genovese F, Karsdal MA, et al. Endotrophin as a marker of complications in a type 2 diabetes cohort. Diabetes Care. 2022;45(11):2746\u20138.","journal-title":"Diabetes Care"},{"issue":"5","key":"5153_CR8","doi-asserted-by":"publisher","first-page":"809","DOI":"10.34067\/KID.0000422021","volume":"3","author":"N Sparding","year":"2022","unstructured":"Sparding N, Rasmussen DGK, Genovese F, Karsdal MA, Hornum M, Feldt-Rasmussen B, et al. Circulating levels of endotrophin are prognostic for long-term mortality after AKI. Kidney360. 2022;3(5):809\u201317.","journal-title":"Kidney360"},{"issue":"8","key":"5153_CR9","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.34067\/KID.0000000000000507","volume":"5","author":"AH Flannery","year":"2024","unstructured":"Flannery AH, Bu D, Botkins M, Gianella F, Zhang N, An Z, et al. Endotrophin as a biomarker for severe acute kidney injury and major adverse kidney events. Kidney360. 2024;5(8):1087\u201393.","journal-title":"Kidney360"},{"issue":"6","key":"5153_CR10","doi-asserted-by":"publisher","first-page":"100355","DOI":"10.1016\/j.jhepr.2021.100355","volume":"3","author":"AJC Kerbert","year":"2021","unstructured":"Kerbert AJC, Gupta S, Alabsawy E, Dobler I, L\u00f8nsmann I, Hall A, et al. Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure. JHEP Rep. 2021;3(6):100355.","journal-title":"JHEP Rep"},{"issue":"10","key":"5153_CR11","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1038\/s12276-020-00520-8","volume":"52","author":"M Kim","year":"2020","unstructured":"Kim M, Lee C, Seo DY, Lee H, Horton JD, Park J, et al. The impact of endotrophin on the progression of chronic liver disease. Exp Mol Med. 2020;52(10):1766\u201376.","journal-title":"Exp Mol Med"},{"issue":"1","key":"5153_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12931-020-01461-6","volume":"21","author":"SR R\u00f8nnow","year":"2020","unstructured":"R\u00f8nnow SR, Langholm LL, Karsdal MA, Manon-Jensen T, Tal-Singer R, Miller BE, et al. Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort. Respir Res. 2020;21(1):202.","journal-title":"Respir Res"},{"issue":"1","key":"5153_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12931-019-1118-7","volume":"20","author":"LA Organ","year":"2019","unstructured":"Organ LA, Duggan AR, Oballa E, Taggart SC, Simpson JK, Kang\u2019ombe AR, et al. Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort. Respir Res. 2019;20(1):148.","journal-title":"Respir Res"},{"issue":"4","key":"5153_CR14","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/1756-185X.13804","volume":"23","author":"S Kubo","year":"2020","unstructured":"Kubo S, Siebuhr AS, Bay-Jensen AC, Juhl P, Karsdal MA, Satoh Y, et al. Correlation between serological biomarkers of extracellular matrix turnover and lung fibrosis and pulmonary artery hypertension in patients with systemic sclerosis. Int J Rheum Dis. 2020;23(4):532\u20139.","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"5153_CR15","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s40744-022-00444-x","volume":"9","author":"G Schett","year":"2022","unstructured":"Schett G, Loza MJ, Palanichamy A, FitzGerald O, Ritchlin C, Bay-Jensen AC, et al. Collagen turnover biomarkers associate with active psoriatic arthritis and decrease with guselkumab treatment in a phase 3 clinical trial (DISCOVER-2). Rheumatol Ther. 2022;9(4):1017\u201330.","journal-title":"Rheumatol Ther"},{"issue":"1","key":"5153_CR16","doi-asserted-by":"publisher","first-page":"14713","DOI":"10.1038\/s41598-021-94321-2","volume":"11","author":"M Lindholm","year":"2021","unstructured":"Lindholm M, Godskesen LE, Manon-Jensen T, Kjeldsen J, Krag A, Karsdal MA, et al. Endotrophin and C6Ma3, serological biomarkers of type VI collagen remodelling, reflect endoscopic and clinical disease activity in IBD. Sci Rep. 2021;11(1):14713.","journal-title":"Sci Rep"},{"key":"5153_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2024.06.003","volume":"132","author":"F Genovese","year":"2024","unstructured":"Genovese F, Bager C, Frederiksen P, Vazquez D, Sand JMB, Jenkins RG, et al. The fibroblast hormone endotrophin is a biomarker of mortality in chronic diseases. Matrix Biol. 2024;132:1\u20139.","journal-title":"Matrix Biol"},{"issue":"2","key":"5153_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41588-024-02052-7","volume":"57","author":"S Yoshiji","year":"2025","unstructured":"Yoshiji S, Lu T, Butler-Laporte G, Carrasco-Zanini-Sanchez J, Su CY, Chen Y, et al. Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease. Nat Genet. 2025;57(2):345\u201357.","journal-title":"Nat Genet"},{"issue":"6","key":"5153_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.120.052430","volume":"144","author":"AP Patel","year":"2021","unstructured":"Patel AP, Wang M, Kartoun U, Ng K, Khera AV. Quantifying and understanding the higher risk of atherosclerotic cardiovascular disease among South Asian individuals: results from the UK biobank prospective cohort study. Circulation. 2021;144(6):410\u201322.","journal-title":"Circulation"},{"issue":"11","key":"5153_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-089149","volume":"14","author":"R Rauf","year":"2024","unstructured":"Rauf R, Khan MN, Sial JA, Qamar N, Saghir T, Kazmi KA. Primary prevention of cardiovascular diseases among women in a South Asian population: a descriptive study of modifiable risk factors. BMJ Open. 2024;14(11):e089149.","journal-title":"BMJ Open"},{"issue":"1","key":"5153_CR21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12872-024-03811-4","volume":"24","author":"RT Short","year":"2024","unstructured":"Short RT, Lin F, Nair S, Terry JG, Carr JJ, Kandula NR, et al. Comparing coronary artery cross-sectional area among asymptomatic South Asian, White, and Black participants: the MASALA and CARDIA studies. BMC Cardiovasc Disord. 2024;24(1):158.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"5153_CR22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12872-024-04036-1","volume":"24","author":"G Peerwani","year":"2024","unstructured":"Peerwani G, Hanif B, Rahim KA, Kashif M, Virani SS, Sheikh S. Presentation, management, and early outcomes of young acute coronary syndrome patients- analysis of 23,560 South Asian patients from 2012 to 2021. BMC Cardiovasc Disord. 2024;24(1):378.","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"5153_CR23","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2337\/dc22-1786","volume":"46","author":"R Retnakaran","year":"2023","unstructured":"Retnakaran R, Ye C, Hanley AJ, Connelly PW, Sermer M, Zinman B. Treatment of gestational diabetes mellitus and maternal risk of diabetes after pregnancy. Diabetes Care. 2023;46(3):587\u201392.","journal-title":"Diabetes Care"},{"key":"5153_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101087","volume":"40","author":"R Retnakaran","year":"2021","unstructured":"Retnakaran R, Ye C, Hanley AJ, Connelly PW, Sermer M, Zinman B. Subtypes of gestational diabetes and future risk of pre-diabetes or diabetes. EClinicalMedicine. 2021;40:101087.","journal-title":"EClinicalMedicine"},{"key":"5153_CR25","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.2337\/dc14-1529","volume":"37","author":"CK Kramer","year":"2014","unstructured":"Kramer CK, Swaminathan B, Hanley AJ, Connelly PW, Sermer M, Zinman B, et al. Each degree of glucose intolerance in pregnancy predicts distinct trajectories of beta-cell function, insulin sensitivity and glycemia in the first 3 years postpartum. Diabetes Care. 2014;37:3262\u20139.","journal-title":"Diabetes Care"},{"issue":"5","key":"5153_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S2213-8587(23)00062-1","volume":"11","author":"A Bardugo","year":"2023","unstructured":"Bardugo A, Bendor CD, Rotem RS, Tsur AM, Derazne E, Gerstein HC, et al. Glucose intolerance in pregnancy and risk of early-onset type 2 diabetes: a population-based cohort study. Lancet Diabetes Endocrinol. 2023;11(5):333\u201344.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"5153_CR27","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S2213-8587(19)30077-4","volume":"7","author":"R Retnakaran","year":"2019","unstructured":"Retnakaran R, Shah BR. Glucose screening in pregnancy and future risk of cardiovascular disease in women: a population-based study. Lancet Diabetes Endocrinol. 2019;7(5):378\u201384.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"5153_CR28","doi-asserted-by":"crossref","unstructured":"Diabetes Canada Clinical Practice Guidelines Expert Committee. Punthakee Z, Goldenberg R, Katz P. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes. 2018;42(Suppl 1):S10-S15.","DOI":"10.1016\/j.jcjd.2017.10.003"},{"issue":"7","key":"5153_CR29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"issue":"8","key":"5153_CR30","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1038\/oby.2008.307","volume":"16","author":"R Retnakaran","year":"2008","unstructured":"Retnakaran R, Shen S, Hanley AJ, Vuksan V, Hamilton JK, Zinman B. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity. 2008;16(8):1901\u20137.","journal-title":"Obesity"},{"key":"5153_CR31","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/j.1464-5491.2009.02841.x","volume":"26","author":"R Retnakaran","year":"2009","unstructured":"Retnakaran R, Qi Y, Goran M, Hamilton J. Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med. 2009;26:1198\u2013203.","journal-title":"Diabet Med"},{"issue":"4","key":"5153_CR32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/00365521.2021.1879249","volume":"56","author":"H Hagstr\u00f6m","year":"2021","unstructured":"Hagstr\u00f6m H, Bu D, Nasr P, Ekstedt M, Hegmar H, Kechagias S, et al. Serum levels of endotrophin are associated with nonalcoholic steatohepatitis. Scand J Gastroenterol. 2021;56(4):437\u201344.","journal-title":"Scand J Gastroenterol"},{"key":"5153_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103391","volume":"68","author":"LM Staunstrup","year":"2021","unstructured":"Staunstrup LM, Bager CL, Frederiksen P, Helge JW, Brunak S, Christiansen C, et al. Endotrophin is associated with chronic multimorbidity and all-cause mortality in a cohort of elderly women. EBioMedicine. 2021;68:103391.","journal-title":"EBioMedicine"},{"issue":"2","key":"5153_CR34","volume":"2","author":"A Agarwala","year":"2023","unstructured":"Agarwala A, Satish P, Rifai MA, Mehta A, Cainzos-Achirica M, Shah NS, et al. Identification and management of atherosclerotic cardiovascular disease risk in South Asian populations in the U.S. JACC: Advances. 2023;2(2):100258.","journal-title":"JACC: Advances"},{"issue":"6","key":"5153_CR35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1161\/CIRCULATIONAHA.121.055159","volume":"144","author":"NR Kandula","year":"2021","unstructured":"Kandula NR, Kanaya AM. The South Asian enigma: solving a puzzle of global importance. Circulation. 2021;144(6):423\u20135.","journal-title":"Circulation"},{"key":"5153_CR36","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.2337\/dc06-0867","volume":"29","author":"R Retnakaran","year":"2006","unstructured":"Retnakaran R, Hanley AJ, Zinman B. Does hypoadiponectinemia explain the increased risk of diabetes and cardiovascular disease in South Asians? Diabetes Care. 2006;29:1950\u20134.","journal-title":"Diabetes Care"},{"issue":"5","key":"5153_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/jpm15050205","volume":"15","author":"A Cersosimo","year":"2025","unstructured":"Cersosimo A, Zito E, Pierucci N, Matteucci A, La Fazia VM. A talk with ChatGPT: the role of artificial intelligence in shaping the future of cardiology and electrophysiology. J Pers Med. 2025;15(5):205.","journal-title":"J Pers Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05153-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05153-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05153-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:32:48Z","timestamp":1759152768000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05153-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5153"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05153-1","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Mount Sinai Hospital Research Ethics Board and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"PS, ZA, and NZ were inventors of patent applications filed by the University of Texas System covering anti-endotrophin antibodies and their uses. RR, DB, JP, PWC, AJH and BZ have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"689"}}